Showing results for "Drugs" in Science & Engineering

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.

Beginning with opium, the “joy plant,” which has been used for 10,000 years, Thomas Hager tells a captivating story of medicine. His subjects include the largely forgotten female pioneer who introduced smallpox inoculation to Britain, the infamous knockout drops, the first antibiotic, which saved countless lives, the first antipsychotic, which helped empty public mental hospitals, Viagra, statins, and the new frontier of monoclonal antibodies. This is a deep, wide-ranging, and wildly entertaining book.

The search to find medicines is as old as disease, which is to say as old as the human race. Through serendipity - by chewing, brewing, and snorting - some Neolithic souls discovered opium, alcohol, snakeroot, juniper, frankincense, and other helpful substances. Ötzi the Iceman, the 5,000-year-old hunter frozen in the Italian Alps, was found to have whipworms in his intestines and Bronze Age medicine, a worm-killing birch fungus, knotted to his leggings.

Despite advances in health care, infectious microbes continue to be a formidable adversary to scientists and doctors. Vaccines and antibiotics, the mainstays of modern medicine, have not been able to conquer infectious microbes because of their amazing ability to adapt, evolve, and spread to new places. Terrorism aside, one of the greatest dangers from infectious disease we face today is from a massive outbreak of drug-resistant microbes.

A podcast that explores the nuanced realities of drug use; literal (psychedelics, pharmaceuticals, recreational drugs) and metaphorical ("drugs" like love, power, religion, fame)—through personal stories, expert insights, and cultural analysis. Hosted by Bukky Fadipe Hosted on Acast. See acast.com/privacy for more information.

At drug cultures, we pull the veil back on one of the most taboo topics, exploring the ways in which cultures throughout history have used psychoactive substances. Join your host Skye Hawthorne on a journey through the strange world of drugs past and present, and how they've been embraced, incorporated, or shunned by societies worldwide.

Is there a pill for love? What about an "anti-love drug", to help us get over an ex? This book argues that certain psychoactive substances, including MDMA - the active ingredient in Ecstasy - may help ordinary couples work through relationship difficulties and strengthen their connection. Others may help sever an emotional connection during a breakup. These substances already exist, and they have transformative implications for how we think about love.

Welcome to "Drug Diaries," the podcast exploring pharmaceuticals, life sciences, and biotechnology. Host Kaushik Trivedi, with over two decades of industry experience, shares his expertise. Kaushik has worked with IQVIA, Cognizant, Wipro, and more, and holds degrees in pharmaceutical chemistry, marketing, and advertising. Kaushik's expertise spans: - Data-Driven GTM & Customer Engagement - CRM, Marketing Cloud, SFE, & Commercial Analytics - AI/ML/NLP in Life Sciences - Population Health Management - IoT & Connected Devices - Content Production & MLR Approval - R&D, Clinical, Pharmacovigilance,...

The explosion of Internet commerce, coupled with globalization and increased pharmaceutical use, has led to an unprecedented vulnerability in the US drug supply. Today, an estimated 80 percent of our drugs are manufactured overseas, mostly in India and China. Every link along this supply chain offers an opportunity for counterfeiters, and increasingly, they are breaking in. Even when the US system works, consumers are increasingly circumventing the safeguards. Skyrocketing health care costs in the US have forced more Americans to become "medical tourists" seeking drugs, life-saving treatments, and transplants abroad, sometimes in countries with rampant counterfeit drug problems and no FDA. Bitter Pills will heighten the public's awareness about counterfeit drugs, critically examine possible solutions, and help people protect themselves.

Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.

Transcribed from the original lectures recorded at San Francisco State University in 1987, The Nature of Drugs series highlights Shulgin’s engaging lecture style peppered with illuminating anecdotes and amusing asides. Ostensibly taught as an introductory course on drugs and biochemistry, these books serve as both a historical record of Shulgin’s teaching style and the culmination of his philosophy on drugs, psychopharmacology, states of consciousness, and societal and individual freedoms pertaining to their use, both medicinal and exploratory.

A renowned neuroscientist provides an “unorthodox but enlightening” (Wall Street Journal) narrative of how addiction happens in the brain, and what we can do to overcome it Through the vivid, true stories of five people who journeyed into and out of addiction, a renowned neuroscientist—and...

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health, while contributing trillions of dollars to the global economy. In spite of these past successes - and indeed because of them - our ability to deliver new medicines may be quickly coming to an end. Moving from the 20th century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.

From one of the world's foremost experts on the subject, a powerful argument that the greatest damage from drugs flows from their being illegal, and a hopeful reckoning with the possibility of their use as part of a responsible and happy life Dr. Carl L. Hart, Ziff Professor at Columbia...

Think about all of the things you consider every day to help keep yourself, your loved ones, and your community happy, healthy, and hopeful. Now consider this: There is an ever-growing body of research demonstrating significant negative impacts, for yourself and the ones you love, in the consumption of pornography. It can change the way you think, harm your ability to connect with other people, and can contribute to changing the world in negative ways. Join us every other week as we consider the harmful effects of pornography using science, facts, and personal accounts. Consider Before ...

An authoritative and eye-opening history that examines how Monsanto came to have outsized influence over our food system. Monsanto, a St. Louis chemical firm that became the world’s largest maker of genetically engineered seeds, merged with German pharma-biotech giant Bayer in 2018—but its...

Hard Drugs is a show by Saloni Dattani and Jacob Trefethen about medical innovation: how to speed it up, how to scale it up, and how to make sure lifesaving tools reach the people who need them the most. It is brought to you by Works in Progress and Coefficient Giving.

Ever wondered what's really happening behind the scenes in the biotech and pharmaceutical industry? Drug Dealin' pulls back the curtain. Co-hosts Shivu Sharma and Kenny Lalwani, two seasoned BioPharma professionals, offer unparalleled insider insights, dissecting the latest news, trends, and catalysts. Each episode features in-depth discussions and interviews with industry luminaries, giving you honest and unvarnished perspectives you won't find anywhere else.

In this series, we discuss the evolving landscape of obesity drug development, exploring the science, patient experiences, and clinical trial innovations that are shaping a new era in care. Through candid conversations with advocates like Sarah Le Brocq and expert insights from host Claudia Filozof, the podcast examines obesity as a complex, chronic disease—challenging stigma, highlighting the importance of empathy in healthcare, and advocating for patient-centric approaches in clinical research.

Imagining another drug world together